These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16092096)

  • 1. Treatment of progressive supranuclear palsy and corticobasal degeneration.
    Lang AE
    Mov Disord; 2005 Aug; 20 Suppl 12():S83-91. PubMed ID: 16092096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive dopamine neuron loss in progressive supranuclear palsy.
    Murphy KE; Karaconji T; Hardman CD; Halliday GM
    Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
    Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
    Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of corticobasal degeneration].
    Farsang M; Takáts A; Szirmai I; Kovács T
    Ideggyogy Sz; 2005 Jan; 58(1-2):45-51. PubMed ID: 15884398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropathological features in corticobasal degeneration and progressive supranuclear palsy].
    Wakabayashi K; Takahashi H
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1155-7. PubMed ID: 12784692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy for progressive supranuclear palsy and corticobasal degeneration].
    Morimatsu M
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1485-92. PubMed ID: 13677899
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases.
    De Bruin VM; Lees AJ
    Mov Disord; 1994 Jul; 9(4):381-9. PubMed ID: 7969203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine-induced myoclonus in a patient with progressive supranuclear palsy.
    Yarnall AJ; Burn DJ
    Age Ageing; 2012 Sep; 41(5):695-6. PubMed ID: 22421702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive supranuclear palsy and corticobasal degeneration.
    Litvan I
    Baillieres Clin Neurol; 1997 Apr; 6(1):167-85. PubMed ID: 9426874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease. Diagnosis and the initiation of therapy.
    Bhat V; Weiner WJ
    Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary progressive freezing gait: a syndrome with many causes.
    Factor SA; Higgins DS; Qian J
    Neurology; 2006 Feb; 66(3):411-4. PubMed ID: 16476942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
    Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW
    Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of progressive supranuclear palsy].
    Finali G; Piccinin GL; Piccirilli M; Stefano E
    Clin Ter; 1989 Jun; 129(5):339-51. PubMed ID: 2569956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.
    Boeve BF; Lang AE; Litvan I
    Ann Neurol; 2003; 54 Suppl 5():S15-9. PubMed ID: 12833363
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
    Birdi S; Rajput AH; Fenton M; Donat JR; Rozdilsky B; Robinson C; Macaulay R; George D
    Mov Disord; 2002 Nov; 17(6):1255-64. PubMed ID: 12465065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
    Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy.
    Hardman CD; Halliday GM
    Mov Disord; 1999 Jul; 14(4):626-33. PubMed ID: 10435500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.